1)下瀬川徹:厚生労働科学研究費補助金難治性疾患克服研究事業難治性膵疾患に関する調査研究,平成23年度〜25年度総合研究報告書.pp61-73, 2014
2)Masamune A, et al:Clinical practice of acute pancreatitis in Japan;Ananalysis of nationwide epidemiological survey in 2016. Pancreatology 20:629-636, 2020
3)急性膵炎診療ガイドライン2015改訂出版委員会,他(編):急性膵炎診療ガイドライン2015.金原出版,2015
4)Takeda K, et al:Pancreatic ischemia associated with vasospasm in the early phase of human acute necrotizing pancreatitis. Pancreas 30;40-49, 2005
5)Inoue K, et al:Further evidence for endothelin as an important mediator of pancreatic and instestinal ischemia in severe acute pancreatitis. Pancreas 26:218-223, 2003
6)Takeda K, et al:Benefit of continuous regional arterial infusion of protease inhibitor and antibiotics in the management of acute necrotizing pancreatitis. Pancreatology 1:668-673, 2001
7)Piascik M,et al:The results of severe acute pancreatitis treatment with continuous regional arterial infusion of protease inhibitor and antibiotic;A randomized controlled study. Pancreas 39:863-867, 2010
8)Hamada T, et al:Continuous regional arterial infusion for acute pancreatitis;A propensity score analysis using a nationwide administrative database. Crit Care 17:R214, 2013
9)Banks PA, et al:Classification of acute pancreatitis-2012;Revision of the Atlanta classification and definitions by international consensus. Gut 62:102-111:2013
10)van Santvoort HC, et al:A step-up approach or open necrosectomy for necrotizing pancreatitis. N Engl J Med 362:1491-1502, 2010